BACKGROUND AND AIMS: As NSAIDs can cause serious upper gastrointestinal harm, guidelines have been established for the prescribing of proton pump inhibitors (PPIs) in high-risk patients using NSAIDs. Studies examining guideline compliance in surgical patients are scarce. Therefore, a retrospective cross-sectional database study was carried out aimed at determining the proportion of noncompliance with the Dutch guideline and determining the association of several factors with this noncompliance. MATERIALS AND METHODS: Hospital admissions of patients on surgical wards of Erasmus University Medical Center between 1 January 2013 and 1 August 2014 were included in which an NSAID was newly prescribed. Preadmission PPI use was excluded. The main outcome was the proportion of noncompliance with the guideline. As a secondary outcome, the association of several potential risk factors with noncompliance was assessed. The proportion of guideline noncompliance was calculated as the percentage of all included surgical ward admissions. For the secondary analysis, univariate and multivariable logistic regression analyses were carried out. RESULTS: A total of 409 admissions were included. The proportion of admissions in which guideline noncompliance was present was 46.6%, mostly because of incorrectly added PPIs. Coxib use [adjusted odds ratio 0.22 (95% confidence interval 0.12-0.44)], polypharmacy (the use of five or more drugs) [2.18 (1.27-3.76)], and the surgical wards orthopedics [22.32 (5.38-92.55)], plastic surgery [10.82 (2.51-46.59)], trauma surgery [5.78 (1.47-22.70)], and transplant/vascular surgery [4.45 (1.10-18.00)] were statistically significantly associated with noncompliance. CONCLUSION: Noncompliance with the guideline on NSAID use and gastroprotection is present in almost half of surgical hospital admissions and mainly involves overprescribing.
BACKGROUND AND AIMS: As NSAIDs can cause serious upper gastrointestinal harm, guidelines have been established for the prescribing of proton pump inhibitors (PPIs) in high-risk patients using NSAIDs. Studies examining guideline compliance in surgical patients are scarce. Therefore, a retrospective cross-sectional database study was carried out aimed at determining the proportion of noncompliance with the Dutch guideline and determining the association of several factors with this noncompliance. MATERIALS AND METHODS: Hospital admissions of patients on surgical wards of Erasmus University Medical Center between 1 January 2013 and 1 August 2014 were included in which an NSAID was newly prescribed. Preadmission PPI use was excluded. The main outcome was the proportion of noncompliance with the guideline. As a secondary outcome, the association of several potential risk factors with noncompliance was assessed. The proportion of guideline noncompliance was calculated as the percentage of all included surgical ward admissions. For the secondary analysis, univariate and multivariable logistic regression analyses were carried out. RESULTS: A total of 409 admissions were included. The proportion of admissions in which guideline noncompliance was present was 46.6%, mostly because of incorrectly added PPIs. Coxib use [adjusted odds ratio 0.22 (95% confidence interval 0.12-0.44)], polypharmacy (the use of five or more drugs) [2.18 (1.27-3.76)], and the surgical wards orthopedics [22.32 (5.38-92.55)], plastic surgery [10.82 (2.51-46.59)], trauma surgery [5.78 (1.47-22.70)], and transplant/vascular surgery [4.45 (1.10-18.00)] were statistically significantly associated with noncompliance. CONCLUSION: Noncompliance with the guideline on NSAID use and gastroprotection is present in almost half of surgical hospital admissions and mainly involves overprescribing.
Authors: Jacqueline M Bos; Marijke J C Timmermans; Gerard A Kalkman; Patricia M L A van den Bemt; Peter A G M De Smet; Michel Wensing; Cornelis Kramers; Miranda G H Laurant Journal: PLoS One Date: 2018-08-23 Impact factor: 3.240
Authors: Jacqueline M Bos; Stephanie Natsch; Patricia M L A van den Bemt; Johan L W Pot; J Elsbeth Nagtegaal; Andre Wieringa; Gert Jan van der Wilt; Peter A G M De Smet; Cornelis Kramers Journal: Int J Clin Pharm Date: 2017-11-03
Authors: Jacqueline C Whittemore; Jennifer E Stokes; Nicole L Laia; Joshua M Price; Jan S Suchodolski Journal: PeerJ Date: 2018-07-17 Impact factor: 2.984